U.K.-based Biotech Firm Engitix and Japanese Drugmaker Takeda Have Agreed to Extend Their ... - Latest Tweet by Bloomberg
The latest Tweet by Bloomberg states, 'U.K.-based biotech firm Engitix and Japanese drugmaker Takeda have agreed to extend their existing partnership in a deal could be valued at as much as $300 million ...'
(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)